Chronic pain—regardless of the cause—is often linked to persistent inflammation and cellular damage that disrupt normal signaling pathways. When inflammation remains unresolved, many conventional treatments provide only temporary relief.
Medications may mask discomfort without addressing underlying tissue stress. Surgical options can involve lengthy recovery and potential complications. Advanced cellular therapy offers a minimally invasive approach designed to support repair and reduce inflammatory burden.
See if regenerative therapy may be right for you.
• Arthritis
• Tendinitis
• Long-standing injuries
• Chronic inflammation
• Autoimmune-related pain
• Degenerative joint conditions
• Neurological pain
• Peripheral neuropathy
• Diabetic neuropathy
• Fibromyalgia
• Degenerative joint disease
“Within weeks, the pain in my hand and foot noticeably improved and has not returned.”
Advanced cellular therapy offers new possibilities for individuals who have not found lasting relief with traditional options. At ZignaGenix, our regenerative protocols are designed to work with the body’s natural repair systems to help:
• Reduce inflammatory signaling
• Support healing of damaged tissues
• Improve mobility and flexibility
• Enhance overall quality of life
Discover how regenerative cellular therapy—an advanced, minimally invasive approach—may amplify the body’s natural healing mechanisms to support bone, ligament, tendon, and joint recovery.
• Knee injuries and discomfort
• Hip pain
• Shoulder conditions
• Elbow issues
• Ankle and foot pain
• Wrist and hand discomfort
• Lumbar injuries
• Cervical pain
• Degenerative disc disease
• Herniated or bulging discs
• Sciatica
• Chronic muscular tension
• Carpal tunnel syndrome
• Plantar fasciitis
• Radiculopathy
• Runner’s knee
• Tennis elbow
• Additional chronic pain syndromes
Find out whether regenerative therapy may support meaningful progress in your health journey.
ZignaGenix Hypoxic Cellular Therapy is our signature regenerative program, utilizing high-potency mesenchymal stem cells (MSCs) derived from Wharton’s Jelly umbilical cord tissue. These cells are cultivated under controlled hypoxic (low-oxygen) conditions using proprietary laboratory protocols designed to enhance cellular resilience and biologic activity.
Our advanced cellular platform integrates hypoxic MSCs and MSC-derived exosomes to support immune balance, reduce inflammatory signaling, and promote tissue repair pathways. These cells demonstrate:
A customized regenerative program developed in consultation with our medical team may help support:
• Reduction in persistent pain
• Decreased inflammatory burden
• Faster recovery from injuries or procedures
• Support for tissue regeneration in bones, ligaments, muscles, and joints
• Healing from long-standing injuries